MedTrace Logo

Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

NCT02927223 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2020-01-28

Study results available
· View outcomes & findings →

Summary

To test the hypothesis that increasing the sinus node rate with atropine treatment prior to exercise will reduce exercise-triggered ventricular ectopy compared to baseline in patients with CPVT.

Conditions

  • Catecholaminergic Polymorphic Ventricular Tachycardia

Interventions

DRUG

Atropine

PROCEDURE

Exercise treadmill test

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Prince J Kannankeril, MD, MSCI · Vanderbilt University Medical Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02927223 on ClinicalTrials.gov